课题基金 / 基金详情

Rational strategies for neuronal production and maturation from human cells.

Rational strategies for neuronal production and maturation from human cells.
人类细胞神经元产生和成熟的合理策略。
批准号:
MR/L021129/1
负责人:
Anna Philpott
金额:
$82.53万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

Anna Philpott的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent exciting finding have shown that normal cells from the skin (fibroblasts) can be converted directly to nerve cells by the addition of only 3 or 4 new specific proteins including so-called "proneural factors". This has opened up a wealth of possibilities for using these neurons to study nerve defects in conditions such as Parkinsons outside the body, and as a platform to test drugs that may enhance neural cell function. Moreover, findings in this area may ultimately underpin developments of methods to produce nerve cells to transplant back into patients with diverse neurological deficits. However, for these nerve cells to be used to model disease in a petri dish, or indeed as a supply to replace nerve cells lost in neurological disease, we need to be able to generate lots of mature nerve cells from fibroblasts that come straight from patients (as opposed to fibroblasts that have been chosen specifically for their ability to grow well in the lab). In addition, we need a way to direct the fibroblasts to form the correct type of nerve cell (e.g. cortical neurons for Stroke, dopaminergic nerve cells for Parkinsons disease, motor neurons for spinal cord injury or motor neuron disease). We are using our knowledge of the regulation of the proteins, and specifically a hyperactive protein that we think will drive much better maturation of these nerves as it does in the developing embryo, to create more effective protocols for making mature nerve cells from patient samples. We will see whether nerve cells generated in this way from patient fibroblasts look and behave the same as nerves produced from different patient-derived cells that have been produced in another way, via a stage that converts them to a "naive" form usually found in the early embryo (so called induced pluripotent cells). If we can use our hyperactive protein to enhance generation of mature nerves of specific types, we will then look at the genes turned on in these nerves to further explore why our neuronal differentiation factor is hyperactive.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41598-018-23056-4
发表时间: 2018-03-15
期刊: Scientific reports
影响因子: 4.6
作者: [Gillotin S, Davies JD, Philpott A]
通讯作者: Philpott A
DOI: 10.1016/j.devcel.2017.04.004
发表时间: 2017-05-08
期刊: Developmental cell
影响因子: 11.8
作者: [Azzarelli R, Hurley C, Sznurkowska MK, Rulands S, Hardwick L, Gamper I, Ali F, McCracken L, Hindley C, McDuff F, Nestorowa S, Kemp R, Jones K, Göttgens B, Huch M, Evan G, Simons BD, Winton D, Philpott A]
通讯作者: Philpott A
DOI: 10.1158/1541-7786.mcr-20-0693
发表时间: 2020-12
期刊: Molecular cancer research : MCR
影响因子: --
作者: [Ali FR, Marcos D, Chernukhin I, Woods LM, Parkinson LM, Wylie LA, Papkovskaia TD, Davies JD, Carroll JS, Philpott A]
通讯作者: Philpott A
DOI: 10.1038/s41598-018-33838-5
发表时间: 2018-10-18
期刊: Scientific reports
影响因子: 4.6
作者: [Azzarelli R, Rulands S, Nestorowa S, Davies J, Campinoti S, Gillotin S, Bonfanti P, Göttgens B, Huch M, Simons B, Philpott A]
通讯作者: Philpott A
International Institutional Awards Tranche 1 Cambridge
  • 批准号:
    BB/Y514299/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $34.51万
  • 财政年份:
    2024
  • 负责人:
    Anna Philpott
  • 依托单位:
International Institutional Awards Tranche 2 Cambridge
  • 批准号:
    BB/Z51472X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $7.96万
  • 财政年份:
    2024
  • 负责人:
    Anna Philpott
  • 依托单位:
22ROMITIGATIONFUNDCambridge
  • 批准号:
    BB/X511936/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $36.06万
  • 财政年份:
    2022
  • 负责人:
    Anna Philpott
  • 依托单位:
21ROMITIGATIONFUND Cambridge
  • 批准号:
    BB/W510609/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $29.18万
  • 财政年份:
    2021
  • 负责人:
    Anna Philpott
  • 依托单位:
国内基金
海外基金
Scalable Learning and Optimization: High-dimensional Models and Online Decision-Making Strategies for Big Data Analysis
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
  • 批准号:
    82372743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈卓佳
  • 依托单位:
放疗通过激活GSDMD诱发细胞焦亡促进肿瘤再增殖的机制研究及干预策略探讨
  • 批准号:
    82373299
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    程进
  • 依托单位:
面向人工智能生成内容的风险识别与治理策略研究
  • 批准号:
    72304290
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    向安玲
  • 依托单位: